CatalYm is a biotech company based in Martinsried near Munich, developing innovative immunotherapies to transform cancer patients' lives by effectively engaging their own immune systems to combat this malignant disease. We are now advancing to Phase 2b studies to confirm visugromab, our lead antibody, that has demonstrated durable anti-tumor efficacy with long-lasting objective responses in. click apply for full job details